首页> 美国卫生研究院文献>Applied and Environmental Microbiology >Increasing Avermectin Production in Streptomyces avermitilis by Manipulating the Expression of a Novel TetR-Family Regulator and Its Target Gene Product
【2h】

Increasing Avermectin Production in Streptomyces avermitilis by Manipulating the Expression of a Novel TetR-Family Regulator and Its Target Gene Product

机译:通过操纵新型TetR家族调节剂及其靶基因产物的表达来增加阿维链霉菌中阿维菌素的产量

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Avermectins produced by Streptomyces avermitilis are commercially important anthelmintic agents. The detailed regulatory mechanisms of avermectin biosynthesis remain unclear. Here, we identified SAV3619, a TetR-family transcriptional regulator designated AveT, to be an activator for both avermectin production and morphological differentiation in S. avermitilis. AveT was shown to indirectly stimulate avermectin production by affecting transcription of the cluster-situated activator gene aveR. AveT directly repressed transcription of its own gene (aveT), adjacent gene pepD2 (sav_3620), sav_7490 (designated aveM), and sav_7491 by binding to an 18-bp perfect palindromic sequence (CGAAACGKTKYCGTTTCG, where K is T or G and Y is T or C and where the underlining indicates inverted repeats) within their promoter regions. aveM (which encodes a putative transmembrane efflux protein belonging to the major facilitator superfamily [MFS]), the important target gene of AveT, had a striking negative effect on avermectin production and morphological differentiation. Overexpression of aveT and deletion of aveM in wild-type and industrial strains of S. avermitilis led to clear increases in the levels of avermectin production. In vitro gel-shift assays suggested that C-5–O-B1, the late pathway precursor of avermectin B1, acts as an AveT ligand. Taken together, our findings indicate positive-feedback regulation of aveT expression and avermectin production by a late pathway intermediate and provide the basis for an efficient strategy to increase avermectin production in S. avermitilis by manipulation of AveT and its target gene product, AveM.
机译:阿维链霉菌产生的阿维菌素是商业上重要的驱虫药。阿维菌素生物合成的详细调控机制仍不清楚。在这里,我们确定了SAV3619(一种称为AveT的TetR家族转录调节因子)既是阿维菌素生产又是阿维链霉菌形态分化的激活剂。已显示,AveT通过影响簇状激活基因aveR的转录而间接刺激阿维菌素的产生。 AveT通过结合18 bp完美回文序列(CGAAACGKTKYCGTTTCG,其中K为T或G,Y为T或C,其中下划线表示其启动子区域内的反向重复)。 aveM(编码假定的跨膜外排蛋白,属于主要的促进子超家族[MFS]),它是AveT的重要靶基因,对阿维菌素的产生和形态分化具有显着的负面影响。阿维链霉菌的野生型和工业菌株中aveT的过表达和aveM的缺失导致阿维菌素产量的明显增加。体外凝胶迁移试验表明,阿维菌素B1的晚期通路前体C-5–O-B1作为AveT配体。综上所述,我们的发现表明,晚期途径中间体对aveT表达和阿维菌素的正反馈调节,并为通过操纵AveT及其靶基因产物AveM来提高阿维链霉菌中阿维菌素产量的有效策略提供了基础。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号